In an emotional email to close friends, Fonda shared her diagnosis of non-lymphoma Hodgkin’s disease, a cancer type known for its favorable response to treatment, with a typical survival rate of only twenty percent. She considers herself fortunate to have access to health insurance and top-tier medical specialists, recognizing the privilege not universally available in the United States.
To address this disparity, Fonda advocates for broader discussions on cancer prevention and its links to various factors, including fossil fuels and pollutants like insecticides derived from them. Despite facing six months of chemotherapy, Fonda remains steadfast in her commitment to climate advocacy, underscoring her resilience and determination.
Non-lymphoma Hodgkin’s is the most prevalent form of lymphoma, originating in the lymphatic system—an integral part of the immune system tasked with protecting against external infections. Breakthroughs in diagnosis and therapy have notably improved the quality of life for patients living with this type of cancer, as noted by the American Cancer Society.